Acceptance and valued-living in palliative care patients, caregivers and significant others

Not Applicable

• Conditions: Depression and Prolonged Grief; Mental Health - Depression; Mental Health - Other mental health disorders

• Registration Number: ACTRN12614000150640
• Lead Sponsor: niversity of Wollongong

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-02-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 460

Inclusion Criteria

Participants need to be aged 18 years or over and have sufficient comprehension of English to be able to understand and complete the study documents. Caregivers are identified by the patient as the primary informal caregiver; that is, the person who spends most time with the patient, who provides most of their informal day-to-day care, assistance and support. Significant others are identified by the patient or caregiver as a significant other who provides informal care, assistance or support and is perceived as being substantially affected by the patient’s situation.

Exclusion Criteria

Individuals with active psychosis, intellectual disability, moderate to severe cognitive impairment, or insufficient comprehension of English that would impair their ability to give informed consent and provide valid responses.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acceptance (also known in the negative as experiential avoidance), measured by the Acceptance and Action Questionnaire - II [Pretreatment, 1 month posttreatment, 6 months postbereavement]

Secondary Outcome Measures

Name	Time	Method
Depression, measured by the Hospital Anxiety and Depression Scale [Pretreatment, 1 month posttreatment, 6 months postbereavement];Prolonged Grief, measured by the Prolonged Grief - 12 (preloss) and Prolonged Grief - 13 (postloss)[Pretreatment, 1 month posttreatment, 6 months postbereavement];Valued-living, measured by the Valued Living Questionnaire[Pretreatment, 1 month posttreatment, 6 months postbereavement]